AI-driven stem cell therapies for chronic diseases. Innovating with precision to manufacture cells and tissues at scale.
CellVoyant Technologies has raised $9.7M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
CellVoyant Technologies's investors include Air Street Capital, Octopus Ventures, Verve Ventures, Compound, Horizons Ventures.
CellVoyant Technologies is headquartered in Bristol, United Kingdom.
AI-driven stem cell therapies for chronic diseases. Innovating with precision to manufacture cells and tissues at scale.
CellVoyant Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellVoyant Technologies — Funding & Investors." VCBacked, January 15, 2024, https://www.vcbacked.co/company/cellvoyant-technologies. Accessed November 14, 2026.
VCBacked. (2024). CellVoyant Technologies — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cellvoyant-technologies
{{cite web |title=CellVoyant Technologies — Funding & Investors |url=https://www.vcbacked.co/company/cellvoyant-technologies |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CellVoyant Technologies? Request a listing update